USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Carl Zeiss Meditec Ag

USPTO PatentsView assignee record - 689 granted patents across 51 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

689

Total patents granted

CPC technology areas

15.9

Avg claims per patent

+8%

5-year filing velocity

The verdict

Carl holds 689 US patents across 51 technology areas, rank #650 of 50,000 tracked assignees.

#650
of 50,000 US assignees by volume: Top 2%
by Innovation Score (62.6/100): 15.9
avg claims per patent: +8%
filing velocity, last 5 yrs

Portfolio overview

Carl Zeiss Meditec Ag has been granted 689 US utility patents between 2015 and 2025, placing Carl Zeiss Meditec Ag at rank #650 across all assignees tracked by PlainPatent. This portfolio spans 51 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.9 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Carl Zeiss Meditec Ag is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Carl sits between Schneider Electric Industries SAS (691 patents, rank #646) and GM Cruise Holdings Llc (685 patents, rank #654) - the closest US assignees by grant volume. The composite Innovation Score of 62.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 358 grants, compared with 331 in the 2015–2019 window, a +8% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Carl Zeiss Meditec Ag's 15.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 51 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Carl Zeiss Meditec Ag against peers pursuing similar technology classes.

Schneider Electri…

691
University of Was…

691
Immatics Biotechn…

690
Rivian IP Holdings

690
Saturn Licensing

689
Carl Zeiss Meditec ◀

689
The Research Foun…

688
Evonik Degussa

686
GM Cruise Holdings

685

What this shows Carl holds 689 patents at rank #650, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Carl

By rank, the assignees closest to #650 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Carl's primary technology class.

Carl's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

63 Top 2% higher than 98% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Carl Zeiss Meditec Ag patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	64	9.3%
2016	62	9.0%
2017	57	8.3%
2018	68	9.9%
2019	80	11.6%
2020	55	8.0%
2021	73	10.6%
2022	59	8.6%
2023	49	7.1%
2024	64	9.3%
2025	58	8.4%

Which technologies does Carl Zeiss Meditec Ag patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 416

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 235

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 168

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 113

G01B - MEASURING LENGTH, THICKNESS OR SIMILAR LINEAR DIMENSIONS; MEASURING ANGLES; MEASURING AREAS; MEASURING IRREGULARITIES OF SURFACES OR CONTOURS 75

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 36

H04N - PICTORIAL COMMUNICATION, e.g. TELEVISION 31

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 29

G06F - ELECTRIC DIGITAL DATA PROCESSING 28

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 26

B23K - SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM 19

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 19

H01S - DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL 18

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 17

G02C - SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES 12

Top 15 of 51 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#650

Across all tracked assignees

Innovation Score

62.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Carl Zeiss Meditec Ag hold?

Carl Zeiss Meditec Ag holds 689 US granted patents filed between 2015 and 2025, spanning 51 technology areas.

What is Carl Zeiss Meditec Ag's Innovation Score?

Carl Zeiss Meditec Ag has an Innovation Score of 62.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Carl Zeiss Meditec Ag focus on?

Carl Zeiss Meditec Ag's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 416 patents. The company has filed patents in 51 CPC subclasses total.

Is Carl Zeiss Meditec Ag's patent filing rate increasing or decreasing?

Carl Zeiss Meditec Ag's recent filing velocity is +8% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Carl Zeiss Meditec Ag's patents?

Carl Zeiss Meditec Ag's patents average 15.9 claims each. This falls within the standard range, providing solid legal coverage.

How is the Carl Zeiss Meditec Ag patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Carl's 689 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Carl ranks #650 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.